Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
GENOOX
What Does GENOOX Do?
Genoox is a pioneering company at the intersection of genomics and artificial intelligence. They provide a cloud-based platform, Franklin, designed to streamline the analysis, interpretation, and management of genomic data for healthcare providers, genetic labs, and pharmaceutical companies. By leveraging AI and machine learning, Genoox aims to accelerate genetic diagnosis, enhance rare disease identification, support oncology research, and facilitate drug discovery, ultimately contributing to the advancement of personalized medicine. Their platform helps clinicians and researchers to quickly and accurately turn complex genomic data into actionable insights, improving patient outcomes and advancing scientific understanding. Following its merger with Geneyx in early 2024, Genoox has further solidified its position by offering an even more comprehensive AI-powered genomic platform.
Where Is GENOOX's Headquarters?
HQ Function
Serves as a key corporate and business development hub, focusing on the US market, strategic partnerships, and investor relations within the Silicon Valley ecosystem.
Notable Features:
Located in a prominent Silicon Valley tech corridor, offering access to talent and innovation. Specific building features are not publicly detailed, but it is likely modern office space suitable for a technology-focused company.
Work Culture:
As a company in the AI and genomics space, the culture likely emphasizes innovation, collaboration, scientific rigor, and a fast-paced environment. Employees are driven by the mission to leverage technology to make a significant impact on healthcare and personalized medicine.
HQ Significance:
The Palo Alto office signifies Genoox's presence in a leading global hub for technology and biotechnology, facilitating access to top-tier talent, investment opportunities, and a vibrant ecosystem of innovation.
Values Reflected in HQ: The choice of a Silicon Valley location reflects Genoox's values of innovation, technological advancement, and ambition to be at the forefront of the genomics and AI industries, striving for global impact.
Location:
Genoox supports its global customer base through its strategically located offices in the USA (Palo Alto, CA, and Boston, MA) and its primary R&D center in Israel (Tel Aviv). These locations enable the company to engage with key markets, access diverse talent pools, and drive innovation in genomic data analysis. Their cloud-based platform, Franklin, is accessible worldwide, allowing healthcare providers, genetic laboratories, and researchers globally to utilize their AI-powered genomic interpretation tools for improved patient care and research outcomes.
Street Address:
400 Lambert Ave
City:
Palo Alto
State/Province:
CA
Country:
USA
Where Else Does GENOOX Operate Around the World?
Tel Aviv, Israel
Address: HaBarzel St 38, Tel Aviv-Yafo, Israel
Acts as the core innovation engine for Genoox's technology, tapping into Israel's vibrant 'Silicon Wadi' tech and biotech ecosystem for R&D advancements and engineering talent.
Boston, MA, USA
Address: 101 Arch Street, Suite 1950, Boston, MA 02110
Facilitates engagement with the dense concentration of academic medical centers, research institutions, and biotech/pharma companies in the Boston/Cambridge area, driving platform adoption, collaborations, and market penetration.
Buying Intent Signals for GENOOX
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Who's Leading GENOOX? Meet the Executive Team
As of April 2025, GENOOX' leadership includes:
Who's Investing in GENOOX?
GENOOX has been backed by several prominent investors over the years, including:
What Leadership Changes Has GENOOX Seen Recently?
Genoox has seen some strategic additions to its team. Publicly available information points to at least one significant hire in business development. Comprehensive details on all executive movements are not always broadly publicized for companies of this stage.
New Appointments:
What Technology (Tech Stack) Is Used byGENOOX?
Discover the tools GENOOX uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
GENOOX Email Formats and Examples
Genoox likely utilizes standard corporate email address formats. The most common patterns for technology companies include [first].[last]@genoox.com or [first_initial][last]@genoox.com. These formats facilitate professional communication and are widely adopted.
[first].[last]@genoox.com
Format
amir.trabelsi@genoox.com
Example
80%
Success rate
What's the Latest News About GENOOX?
GlobeNewswire • January 24, 2024
Genoox and Geneyx Merge to Create AI-Powered Genomic Platform for Accelerated Genetic Diagnosis and Drug Discovery
Genoox announced its merger with Geneyx Genomex Ltd., a provider of a SaaS platform for genetic data analysis and interpretation. The merger aims to create a comprehensive, AI-driven genomic platform to enhance genetic diagnosis, particularly for rare diseases and cancer, and to accelerate drug discovery and development....more
PR Newswire • May 9, 2023
Genoox Launches Franklin 3.0, AI-Powered Platform to Enable Faster, More Accurate Genetic Diagnosis
Genoox released Franklin 3.0, a significant update to its AI-powered genomic analysis platform. The new version introduces advanced features designed to improve the speed and accuracy of genetic diagnosis for rare diseases and hereditary cancer, leveraging enhanced machine learning capabilities and an updated user interface....more
Business Wire • November 15, 2022
Genoox Secures $25 Million in Series B Funding to Advance AI-Powered Genomic Analysis Platform
Genoox announced the closure of a $25 million Series B funding round. The investment, co-led by new investor SMRT Holdings and existing investor KIP (Korea Investment Partners), was aimed at further developing its AI-driven genomic analysis platform, expanding its commercial operations, and accelerating its mission to make genomic medicine more accessible globally....more
Highperformr's free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including GENOOX, are just a search away.